181 related articles for article (PubMed ID: 31704598)
1. Fusion Radiomics Features from Conventional MRI Predict MGMT Promoter Methylation Status in Lower Grade Gliomas.
Jiang C; Kong Z; Liu S; Feng S; Zhang Y; Zhu R; Chen W; Wang Y; Lyu Y; You H; Zhao D; Wang R; Wang Y; Ma W; Feng F
Eur J Radiol; 2019 Dec; 121():108714. PubMed ID: 31704598
[TBL] [Abstract][Full Text] [Related]
2.
Kong Z; Lin Y; Jiang C; Li L; Liu Z; Wang Y; Dai C; Liu D; Qin X; Wang Y; Liu Z; Cheng X; Tian J; Ma W
Cancer Imaging; 2019 Aug; 19(1):58. PubMed ID: 31426864
[TBL] [Abstract][Full Text] [Related]
3. MRI-Based Deep-Learning Method for Determining Glioma
Yogananda CGB; Shah BR; Nalawade SS; Murugesan GK; Yu FF; Pinho MC; Wagner BC; Mickey B; Patel TR; Fei B; Madhuranthakam AJ; Maldjian JA
AJNR Am J Neuroradiol; 2021 May; 42(5):845-852. PubMed ID: 33664111
[TBL] [Abstract][Full Text] [Related]
4. Development of A Radiomic Model for
Doniselli FM; Pascuzzo R; Agrò M; Aquino D; Anghileri E; Farinotti M; Pollo B; Paterra R; Cuccarini V; Moscatelli M; DiMeco F; Sconfienza LM
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203308
[TBL] [Abstract][Full Text] [Related]
5. Amide proton transfer weighted and diffusion weighted imaging based radiomics classification algorithm for predicting 1p/19q co-deletion status in low grade gliomas.
Ma A; Yan X; Qu Y; Wen H; Zou X; Liu X; Lu M; Mo J; Wen Z
BMC Med Imaging; 2024 Apr; 24(1):85. PubMed ID: 38600452
[TBL] [Abstract][Full Text] [Related]
6. Predicting glioblastoma molecular subtypes and prognosis with a multimodal model integrating convolutional neural network, radiomics, and semantics.
Zhong S; Ren JX; Yu ZP; Peng YD; Yu CW; Deng D; Xie Y; He ZQ; Duan H; Wu B; Li H; Yang WZ; Bai Y; Sai K; Chen YS; Guo CC; Li DP; Cheng Y; Zhang XH; Mou YG
J Neurosurg; 2023 Aug; 139(2):305-314. PubMed ID: 36461822
[TBL] [Abstract][Full Text] [Related]
7. Prediction of Molecular Mutations in Diffuse Low-Grade Gliomas using MR Imaging Features.
Shboul ZA; Chen J; M Iftekharuddin K
Sci Rep; 2020 Feb; 10(1):3711. PubMed ID: 32111869
[TBL] [Abstract][Full Text] [Related]
8. Prediction of malignant glioma grades using contrast-enhanced T1-weighted and T2-weighted magnetic resonance images based on a radiomic analysis.
Nakamoto T; Takahashi W; Haga A; Takahashi S; Kiryu S; Nawa K; Ohta T; Ozaki S; Nozawa Y; Tanaka S; Mukasa A; Nakagawa K
Sci Rep; 2019 Dec; 9(1):19411. PubMed ID: 31857632
[TBL] [Abstract][Full Text] [Related]
9. Identifying key factors for predicting O6-Methylguanine-DNA methyltransferase status in adult patients with diffuse glioma: a multimodal analysis of demographics, radiomics, and MRI by variable Vision Transformer.
Usuzaki T; Takahashi K; Inamori R; Morishita Y; Shizukuishi T; Takagi H; Ishikuro M; Obara T; Takase K
Neuroradiology; 2024 May; 66(5):761-773. PubMed ID: 38472373
[TBL] [Abstract][Full Text] [Related]
10. Ten genes associated with MGMT promoter methylation predict the prognosis of patients with glioma.
Zhang Y; Zhu J
Oncol Rep; 2019 Feb; 41(2):908-916. PubMed ID: 30535433
[TBL] [Abstract][Full Text] [Related]
11. Residual Deep Convolutional Neural Network Predicts MGMT Methylation Status.
Korfiatis P; Kline TL; Lachance DH; Parney IF; Buckner JC; Erickson BJ
J Digit Imaging; 2017 Oct; 30(5):622-628. PubMed ID: 28785873
[TBL] [Abstract][Full Text] [Related]
12. MGMT promoter methylation status prediction using MRI scans? An extensive experimental evaluation of deep learning models.
Saeed N; Ridzuan M; Alasmawi H; Sobirov I; Yaqub M
Med Image Anal; 2023 Dec; 90():102989. PubMed ID: 37827111
[TBL] [Abstract][Full Text] [Related]
13. Beyond invasive biopsies: using VASARI MRI features to predict grade and molecular parameters in gliomas.
Setyawan NH; Choridah L; Nugroho HA; Malueka RG; Dwianingsih EK
Cancer Imaging; 2024 Jan; 24(1):3. PubMed ID: 38167551
[TBL] [Abstract][Full Text] [Related]
14. Ultra-high-field sodium MRI as biomarker for tumor extent, grade and IDH mutation status in glioma patients.
Regnery S; Behl NGR; Platt T; Weinfurtner N; Windisch P; Deike-Hofmann K; Sahm F; Bendszus M; Debus J; Ladd ME; Schlemmer HP; Rieken S; Adeberg S; Paech D
Neuroimage Clin; 2020; 28():102427. PubMed ID: 33002860
[TBL] [Abstract][Full Text] [Related]
15. Quality assessment of the MRI-radiomics studies for MGMT promoter methylation prediction in glioma: a systematic review and meta-analysis.
Doniselli FM; Pascuzzo R; Mazzi F; Padelli F; Moscatelli M; Akinci D'Antonoli T; Cuocolo R; Aquino D; Cuccarini V; Sconfienza LM
Eur Radiol; 2024 Feb; ():. PubMed ID: 38308012
[TBL] [Abstract][Full Text] [Related]
16. Sub-region based radiomics analysis for prediction of isocitrate dehydrogenase and telomerase reverse transcriptase promoter mutations in diffuse gliomas.
Zhang H; Ouyang Y; Zhang H; Zhang Y; Su R; Zhou B; Yang W; Lei Y; Huang B
Clin Radiol; 2024 May; 79(5):e682-e691. PubMed ID: 38402087
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a machine learning algorithm for predicting diffuse midline glioma, H3 K27-altered, H3 K27 wild-type high-grade glioma, and primary CNS lymphoma of the brain midline in adults.
Lv K; Chen H; Cao X; Du P; Chen J; Liu X; Zhu L; Geng D; Zhang J
J Neurosurg; 2023 Aug; 139(2):393-401. PubMed ID: 36681946
[TBL] [Abstract][Full Text] [Related]
18. MRI-based radiomics features for the non-invasive prediction of FIGO stage in cervical carcinoma: A multi-center study.
Liu Y; Dong TF; Li PJ; Chen LB; Song T
Magn Reson Imaging; 2024 Jul; 110():170-175. PubMed ID: 38035947
[TBL] [Abstract][Full Text] [Related]
19. Fused deep learning paradigm for the prediction of o6-methylguanine-DNA methyltransferase genotype in glioblastoma patients: A neuro-oncological investigation.
Saxena S; Jena B; Mohapatra B; Gupta N; Kalra M; Scartozzi M; Saba L; Suri JS
Comput Biol Med; 2023 Feb; 153():106492. PubMed ID: 36621191
[TBL] [Abstract][Full Text] [Related]
20. Exploring MGMT methylation-driven structural connectivity changes in insular gliomas: a tractography and graph theoretical analysis.
Yang ZC; Yin CD; Yeh FC; Xue BW; Song XY; Li G; Sun SJ; Deng ZH; Hou ZG; Xie J
J Neurooncol; 2024 Jan; 166(1):155-165. PubMed ID: 38150062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
